Literature DB >> 22486458

Surgical-pathologic risk factors of pelvic lymph node metastasis in stage Ib1-IIb cervical cancer.

Donglin Li1, Jing Cai, Yan Kuang, Jin Cao, Zehua Wang.   

Abstract

OBJECTIVE: To study the distribution characteristics and risk factors of cervical cancer lymph node metastasis (LNM).
DESIGN: Retrospective study.
SETTING: Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology and Affiliated Hospital to Zunyi Medical College. POPULATION: 404 women diagnosed with cervical cancer FIGO stage Ib1-IIa who underwent primary radical surgery and 104 women with Ib2-IIb tumors treated with neoadjuvant chemotherapy (NACT) before surgery.
METHODS: Clinicopathological data were collected and analyzed. MAIN OUTCOME MEASURES: Incidence of infiltration, metastasis and pelvic LNM.
RESULTS: In women without NACT, the incidence of infiltration, metastasis and LNM was 7.2, 17.6 and 15.8%, respectively. Metastasis and LNM were significantly associated with advanced FIGO stage and poorer histological grade. The incidence of multiple metastatic lymph nodes (MLNs), bilateral LNM, skip LNM, LNM in primary group and LNM in secondary group was 6.2, 3.0, 6.2%, 11.4 and 4.5%, respectively. Of the 111 MLNs, 13 (11.7%) were common iliac lymph nodes. In the NACT group, infiltration, metastasis and LNM were observed in 10 (9.6%), 24 (23.1%) and 21 (20.1%) of 104 women, respectively. Metastasis and LNM were significantly correlated with moderate cell differentiation.
CONCLUSION: High LNM risk is expected in tumors of IIa stage or higher and in moderately differentiated tumors. Skip metastasis and common iliac LNM are relatively common and therefore should not be neglected. Our results suggest that standardized and complete pelvic lymph node dissection under surgery is an important measure to ensure a therapeutic effect.
© 2012 The Authors Acta Obstetricia et Gynecologica Scandinavica© 2012 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Mesh:

Year:  2012        PMID: 22486458     DOI: 10.1111/j.1600-0412.2012.01415.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  10 in total

Review 1.  Progress in the Study of Lymph Node Metastasis in Early-stage Cervical Cancer.

Authors:  Bang-Xing Huang; Fang Fang
Journal:  Curr Med Sci       Date:  2018-08-20

2.  Circulating Tie2-Expressing Monocytes: A Potential Biomarker for Cervical Cancer.

Authors:  Qing Han; Quan Zhang; Feiquan Ying; Zehua Wang; Yifan Zhang; Lanqing Gong; E Cai; Jiaxian Qian; Jing Cai
Journal:  Onco Targets Ther       Date:  2020-09-07       Impact factor: 4.147

3.  The Effect of Neoadjuvant Chemotherapy on Lymph Node Metastasis of FIGO Stage IB1-IIB Cervical Cancer: A Systematic Review and Meta-Analysis.

Authors:  Bingxin Chen; Liming Wang; Ci Ren; Hui Shen; Wencheng Ding; Da Zhu; Lu Mao; Hui Wang
Journal:  Front Oncol       Date:  2020-11-05       Impact factor: 6.244

4.  Feasibility of an ADC-based radiomics model for predicting pelvic lymph node metastases in patients with stage IB-IIA cervical squamous cell carcinoma.

Authors:  Yan Yan Yu; Rui Zhang; Rui Tong Dong; Qi Yun Hu; Tao Yu; Fan Liu; Ya Hong Luo; Yue Dong
Journal:  Br J Radiol       Date:  2019-04-01       Impact factor: 3.039

5.  Can pelvic lymphadenectomy be omitted in patients with stage IA2, IB1, and IIA1 squamous cell cervical cancer?

Authors:  Yaxian Wang; Tingting Yao; Jin Yu; Jing Li; Qionghua Chen; Zhongqiu Lin
Journal:  Springerplus       Date:  2016-08-05

6.  A new technique of laparoscopic para-aortic lymphadenectomy optimizes perioperative outcome.

Authors:  Yonghong Lin; Li He; Youwen Mei
Journal:  J Gynecol Oncol       Date:  2020-10-26       Impact factor: 4.401

7.  Region-specific Risk Factors for Pelvic Lymph Node Metastasis in Patients with Stage IB1 Cervical Cancer.

Authors:  Jing Zhao; Jing Cai; Hongbo Wang; Weihong Dong; Yuan Zhang; Shaohai Wang; Xiaoqi He; Si Sun; Yuhui Huang; Bangxing Huang; Kay C Willborn; Ping Jiang; Zehua Wang
Journal:  J Cancer       Date:  2021-03-05       Impact factor: 4.207

8.  Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, IB1, and IIA1 Uterine Cervical Cancer.

Authors:  Juan Zhou; Jing Ran; Zhen-Yu He; Song Quan; Qiong-Hua Chen; San-Gang Wu; Jia-Yuan Sun
Journal:  J Cancer       Date:  2015-02-25       Impact factor: 4.207

9.  The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.

Authors:  Yu Liu; Li-Jun Zhao; Ming-Zhu Li; Ming-Xia Li; Jian-Liu Wang; Li-Hui Wei
Journal:  Chin Med J (Engl)       Date:  2015-08-05       Impact factor: 2.628

10.  Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens.

Authors:  Xiao-Li Chen; Guang-Wen Chen; Guo-Hui Xu; Jing Ren; Zhen-Lin Li; Hong Pu; Hang Li
Journal:  Int J Gynecol Cancer       Date:  2018-10       Impact factor: 3.437

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.